LifeVantage Corporation (LFVN)
| Market Cap | 66.46M |
| Revenue (ttm) | 210.05M |
| Net Income (ttm) | 7.86M |
| Shares Out | 12.80M |
| EPS (ttm) | 0.60 |
| PE Ratio | 8.63 |
| Forward PE | 8.85 |
| Dividend | $0.18 (3.47%) |
| Ex-Dividend Date | Mar 2, 2026 |
| Volume | 177,511 |
| Open | 5.50 |
| Previous Close | 5.51 |
| Day's Range | 4.91 - 5.59 |
| 52-Week Range | 3.90 - 15.00 |
| Beta | 0.39 |
| Analysts | Strong Buy |
| Price Target | 11.00 (+111.95%) |
| Earnings Date | May 6, 2026 |
About LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, ... [Read more]
Financial Performance
In fiscal year 2025, LifeVantage's revenue was $228.53 million, an increase of 14.17% compared to the previous year's $200.16 million. Earnings were $9.81 million, an increase of 233.84%.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for LFVN stock is "Strong Buy" and the 12-month stock price target is $11.0.
News
LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026
SALT LAKE CITY, April 22, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellul...
LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack
SALT LAKE CITY, April 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cel...
LifeVantage Inspires with ‘Breakthrough' Announcements at 2026 Momentum Academy in Las Vegas
SALT LAKE CITY, April 20, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cel...
LifeVantage Appointing Terrence Moorehead as Chief Executive Officer
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate opt...
LifeVantage Transcript: Water Tower Research Insights Conference
The session highlighted a transformation from retail to direct sales, a rigorous five-pillar approach to product development, and a strong focus on nutrigenomics. With robust financials, international expansion, and an 18-month innovation cadence, significant growth is anticipated.
LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026
SALT LAKE CITY, April 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cell...
LifeVantage Announces Expansion of its European Footprint with Market Opening in Portugal
SALT LAKE CITY, April 02, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cel...
LifeVantage Transcript: Sidoti March Small-Cap Virtual Conference
The company highlighted strong financials, robust product innovation, and successful integration of a recent acquisition. Growth is expected from international expansion, new product launches, and digital investments, while a CEO succession plan is in progress.
LifeVantage to Participate in the Sidoti Small Cap Conference
SALT LAKE CITY, March 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cell...
LifeVantage Earnings Call Transcript: Q2 2026
Q2 revenue fell 27.8% year-over-year, mainly due to MindBody GLP-1 sales declines amid increased competition from pharmaceuticals, but sequential growth and LoveBiome integration provided some offset. A $2.4M inventory reserve was taken, and a new $60M share repurchase program was announced.
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellul...
LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan
SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level...
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026
SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellu...
Overlooked Stock: LIF 20% Rally on Boosted Guidance
Boosted sales guidance in Life360's (LIF) earnings offered a more than 20% rally for a stock that was initially down more than 50% from its 2025 high. George Tsilis explains how the company gained tra...
LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026
SALT LAKE CITY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellula...
LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration
SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level...
LifeVantage Transcript: 28th Annual ICR Conference 2026
The company is advancing its activation-based product strategy, highlighted by a successful acquisition in the gut health space and rapid integration of new consultants. Investments focus on technology and international expansion, while a revamped compensation plan attracts a broader range of sellers.
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation
SALT LAKE CITY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellu...
LifeVantage to Participate in the 28th Annual ICR Conference
SALT LAKE CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellu...
LifeVantage Transcript: Water Tower Research Fireside Chat Series
The company completed the LoveBiome acquisition, integrated consultants, and launched a synergistic product stack. Scientific studies showed strong results for P84, and international expansion resumed with Iceland. Focus areas for 2026 include subscriptions, e-commerce, and further global growth.
LifeVantage to Participate in Water Tower Fireside Chat on Thursday, December 11, 2025
SALT LAKE CITY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellu...
New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health
SALT LAKE CITY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cell...
LifeVantage Earnings Call Transcript: Q1 2026
Q1 2026 revenue rose 0.7% to $47.6M, with adjusted EBITDA at $3.9M and net income at $2.3M. The LoveBiome acquisition was completed and fully integrated, expanding the addressable market. Full-year revenue is guided at $225M–$240M, with stronger growth expected in the second half.
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2026
SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellu...
LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Academy 2025
SALT LAKE CITY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cell...